179 related articles for article (PubMed ID: 16987450)
1. [Role of atherogenic dyslipidemia in the development of metabolic syndrome].
Real JT; Romero P; Martínez Hervas S; Pedro T; Carmena R; Ascaso JF
Med Clin (Barc); 2006 Sep; 127(9):321-4. PubMed ID: 16987450
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of metabolic syndrome in an elderly community: comparison between three diagnostic methods.
Rigo JC; Vieira JL; Dalacorte RR; Reichert CL
Arq Bras Cardiol; 2009 Aug; 93(2):85-91. PubMed ID: 19838483
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of metabolic syndrome in Gwalior region of Central India: A comparative study using NCEP ATP III, IDF and Harmonized criteria.
Subramani SK; Mahajan S; Chauhan P; Yadav D; Mishra M; Pakkirisamy U; Prasad GBKS
Diabetes Metab Syndr; 2019; 13(1):816-821. PubMed ID: 30641814
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of IDF, ATPIII and CDS in the diagnosis of metabolic syndrome among adult inhabitants in Jiangxi Province, China.
Cheng L; Yan W; Zhu L; Chen Y; Liu J; Xu Y; Ji L; He J
PLoS One; 2017; 12(12):e0189046. PubMed ID: 29216328
[TBL] [Abstract][Full Text] [Related]
7. Lipid accumulation product: a powerful marker of metabolic syndrome in healthy population.
Taverna MJ; Martínez-Larrad MT; Frechtel GD; Serrano-Ríos M
Eur J Endocrinol; 2011 Apr; 164(4):559-67. PubMed ID: 21262912
[TBL] [Abstract][Full Text] [Related]
8. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
[TBL] [Abstract][Full Text] [Related]
9. Lipid-lowering therapy and lipid goal attainment in patients with metabolic syndrome in China: subgroup analysis of the Dyslipidemia International Study-China (DYSIS-China).
Wang F; Ye P; Hu D; Min Y; Zhao S; Wang Y; Mu Y; Yan X; Li Z; Wei Y; Li J;
Atherosclerosis; 2014 Nov; 237(1):99-105. PubMed ID: 25238215
[TBL] [Abstract][Full Text] [Related]
10. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.
Tong PC; Kong AP; So WY; Yang X; Ho CS; Ma RC; Ozaki R; Chow CC; Lam CW; Chan JC; Cockram CS
Diabetes Care; 2007 May; 30(5):1206-11. PubMed ID: 17259472
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of metabolic syndrome and its association with educational inequalities among Brazilian adults: a population-based study.
Gronner MF; Bosi PL; Carvalho AM; Casale G; Contrera D; Pereira MA; Diogo TM; Torquato MT; Souza GM; Oishi J; Leal AM
Braz J Med Biol Res; 2011 Jul; 44(7):713-9. PubMed ID: 21755260
[TBL] [Abstract][Full Text] [Related]
12. Association of metabolic syndrome with chronic obstructive pulmonary disease in an Indian population.
Acharyya A; Shahjahan MD; Mesbah FB; Dey SK; Ali L
Lung India; 2016; 33(4):385-90. PubMed ID: 27578930
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Apolipoprotein (ApoB/ApoA-1) and Lipoprotein (Total Cholesterol/HDL) Ratios in Obese Adolescents.
Alemzadeh R; Kichler J
Metab Syndr Relat Disord; 2018 Feb; 16(1):40-45. PubMed ID: 29154726
[TBL] [Abstract][Full Text] [Related]
14. Burden of metabolic syndrome among HIV-infected patients in Southern Ethiopia.
Tesfaye DY; Kinde S; Medhin G; Megerssa YC; Tadewos A; Tadesse E; Shimelis T
Diabetes Metab Syndr; 2014; 8(2):102-7. PubMed ID: 24907175
[TBL] [Abstract][Full Text] [Related]
15. The hypertriglyceridemic waist phenotype versus the National Cholesterol Education Program-Adult Treatment Panel III and International Diabetes Federation clinical criteria to identify high-risk men with an altered cardiometabolic risk profile.
Blackburn P; Lemieux I; Alméras N; Bergeron J; Côté M; Tremblay A; Lamarche B; Després JP
Metabolism; 2009 Aug; 58(8):1123-30. PubMed ID: 19481769
[TBL] [Abstract][Full Text] [Related]
16. Lipid profiles and associated gene polymorphisms in young Asian Indian patients with acute myocardial infarction and the metabolic syndrome.
Ranjith N; Pegoraro RJ; Rom L
Metab Syndr Relat Disord; 2009 Dec; 7(6):571-8. PubMed ID: 19642912
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of dyslipidemia in the Iraqi adult population.
Mula-Abed WA; Chilmeran SK
Saudi Med J; 2007 Dec; 28(12):1868-74. PubMed ID: 18060219
[TBL] [Abstract][Full Text] [Related]
18. The implications of anthropometric, inflammatory and glycaemic control indices in the epidemiology of the metabolic syndrome given by different definitions: a classification analysis.
Panagiotakos DB; Pitsavos C; Das UN; Skoumas Y; Stefanadis C
Diabetes Obes Metab; 2007 Sep; 9(5):660-8. PubMed ID: 17697058
[TBL] [Abstract][Full Text] [Related]
19. Comparison of two classifications of metabolic syndrome in the pediatric population and the impact of cholesterol.
Prodam F; Ricotti R; Genoni G; Parlamento S; Petri A; Balossini C; Savastio S; Bona G; Bellone S
J Endocrinol Invest; 2013; 36(7):466-73. PubMed ID: 23211535
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation criteria: a population-based study.
Bener A; Zirie M; Musallam M; Khader YS; Al-Hamaq AO
Metab Syndr Relat Disord; 2009 Jun; 7(3):221-9. PubMed ID: 19320557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
